Cyclacel Pharmaceuticals, Inc. announces private placement of 7,956 shares of common stock at an issue price of $3.315 per share and warrants to purchase up to 7,956 shares of common stock with an exercise price of $3.19 per share to members of management for gross proceeds of $26,374.14 on December 22, 2023. The transaction is expected to close on December 26, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.51 USD | -5.62% | -15.17% | -43.45% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.45% | 1.99M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- CYCC Stock
- News Cyclacel Pharmaceuticals, Inc.
- Cyclacel Pharmaceuticals, Inc. announced that it expects to receive $0.026374 million in funding